
President John Dramani Mahama has officially inaugurated two state-of-the-art facilities at the Noguchi Memorial Institute for Medical Research (NMIMR) to strengthen Ghana's health security and forensic capabilities. The new Human Identification (DNA) Laboratory and advanced mRNA and protein vaccine research laboratories at the University of Ghana represent a significant step toward medical self-reliance. These facilities are part of a broader $1 billion government investment in the pharmaceutical industry designed to transform Ghana into a manufacturing hub for West Africa.
The establishment of the DNA laboratory follows a tragic helicopter crash in August 2025, which highlighted the country's forensic limitations when samples had to be sent to South Africa for identification. President Mahama emphasized that the new facility will ensure timely DNA analysis during national emergencies and support local law enforcement without the delays and costs associated with foreign reliance. By localizing these high-tech services, the government aims to enhance the speed of justice and emergency response.
In the area of public health, the vaccine laboratories are equipped to conduct cutting-edge research into mRNA and protein-based treatments. Health Minister Kwabena Mintah Akandoh announced that the first locally bottled vaccines are expected to be available by 2027. President Mahama reiterated his commitment to ending Ghana's dependence on foreign medical resources, stating that the country must empower its own scientists to develop indigenous solutions for future health crises.
This initiative is backed by a $1 billion investment reaffirmed in the 2026 Budget, which seeks to establish dedicated biomanufacturing hubs in the Eastern, Central, and Volta Regions. Beyond scientific research, the project is expected to stimulate the local economy by creating opportunities for Ghanaian businesses and researchers. The government's strategy focuses on building a robust pharmaceutical ecosystem that reduces imports and secures the nation's long-term health sovereignty.
Related topic
John Mahama: Latest News & Updates →